siRNA treatment reduces triglycerides in people with rare problem
.ANALYSIS HIGHLIGHT.19 September 2024.
Plozasiran decreased triglyceride levels through 80% and also lowered the threat of pancreatitis in patients along with chronic chylomicronemia, with or even without a hereditary medical diagnosis.